Archive for January, 2012

Digital health investment opportunities abound, but standouts deliver disruptive change

The convergence of ubiquitous smartphones, wireless Internet, and low-cost monitoring devices, is driving the emergence of a new world of digital health. At the same time, cost pressures on healthcare are creating demand for new ways to not just improv…


Post-Grant Review: The Good, the Bad and the Ugly for Biotechnology Companies

This paper summarizes the Post-Grant Review process, one of the many interesting aspects of patent reform brought about by the enactment of the America Invents Act, and the effect it may have on how Biotechnology companies conduct business and manage t…


Patent litigation in India and interim injunctions — An evolving jurisprudence

This paper attempts to summarize and analyze the judicial trend towards granting or denying interim injunctive relief in patent litigation arena. Full details at the Journal of Commercial Biotechnology


The University of Colorado Certificate Program in Bioinnovation and Entrepreneurship: An interdisciplinary, cross-campus model

In keeping with an emerging literature on the role of business education in the development of entrepreneurially-intentioned biotechnologists, this paper describes the actions and experiences of an entrepreneurship program that began in the late 1990â…


The emergence of bio-clusters in Egypt and South Africa

There is a wide body of literature on biotechnology clusters. However, most of the works has been focused on the description of the clusters as well as the development of biotechnology clusters in USA, Europe and other developed countries. Much less at…


Strategies for collaboration agreements focusing on innovation

Collaborations focusing on innovation are often born with the conception of a technology, typically as a result of one side’s research effort. Collaborations for innovation can also be made through a deliberate process of identifying strategic synerg…


Options to change Medicare payment for outpatient prescription drugs and biotechnology products

The debates over the Obama Administration’s health care reform law, and, more recently, the federal budget deficit and national debt have focused attention on the growth in costs of the Medicare program.  Three approaches to reducing Medicare expend…


Industrial biotechnology – Markets and industry structure

An increasing number of chemicals and materials, like base chemicals and polymers, as well as high value products, such as consumer chemicals and specialty chemicals, are produced using biotechnology in one or more of the process steps. In 2010, the sa…